Research Article

You have full text access to this OnlineOpen article

Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis

  1. Margherita Massa1,
  2. Nick Costouros2,
  3. Federica Mazzoli1,
  4. Fabrizio De Benedetti1,
  5. Antonio La Cava2,
  6. Tho Le2,
  7. Isme de Kleer2,
  8. Angelo Ravelli3,
  9. Margaret Liotta4,
  10. Sarah Roord2,
  11. Charles Berry2,
  12. Lauren M. Pachman4,
  13. Alberto Martini3,
  14. Salvatore Albani2,*

Article first published online: 8 NOV 2002

DOI: 10.1002/art.10566

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 11, pages 3015–3025, November 2002

Additional Information

How to Cite

Massa, M., Costouros, N., Mazzoli, F., De Benedetti, F., La Cava, A., Le, T., de Kleer, I., Ravelli, A., Liotta, M., Roord, S., Berry, C., Pachman, L. M., Martini, A. and Albani, S. (2002), Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis & Rheumatism, 46: 3015–3025. doi: 10.1002/art.10566

Author Information

  1. 1

    IRCCS Policlinico San Matteo, Pavia, Italy

  2. 2

    University of California, San Diego, La Jolla, California, USA

  3. 3

    IRCCS Gaslini, Universita' di Genova, Genoa, Italy

  4. 4

    Northwestern University, Chicago, Illinois, USA

*Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0663

Publication History

  1. Issue published online: 8 NOV 2002
  2. Article first published online: 8 NOV 2002
  3. Manuscript Accepted: 10 JUL 2002
  4. Manuscript Received: 23 JAN 2002

Funded by

  • IRCCS Policlinico San Matteo
  • Italian Ministry of Health. Grant Number: 390RFM/94/01
  • NIH. Grant Numbers: 5P50-AR-44850-04, N01-AR-92241
  • Royal Netherlands Academy of Arts and Sciences

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (142K)

REFERENCES

  • 1
    Cassidy J, Petty R. Textbook of pediatric rheumatology. 3rd ed. Philadelphia: WB Saunders; 1995.
  • 2
    McDouall RM, Dunn MJ, Dubowitz V. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 1990; 99: 199–217.
  • 3
    Pachman LM, O'Gorman MRG, Lawton T, Liotta M, Pope RM, Greene M, et al. Studies of muscle biopsies (MBx) from DQA1*0501+ untreated children with juvenile dermatomyositis (JDM) very early in their disease course: evidence of a TCR Vβ8 motif and increased CD56+ NK cells. Arthritis Rheum 1998; 41 Suppl 9: S203.
  • 4
    Dawkins RL, Mastaglia FL. Cell mediated cytotoxicity to muscle in polymyositis. N Engl J Med 1973; 288: 434–8.
  • 5
    Haas DC, Arnason BGW. Cell-mediated immunity in polymyositis: creatine phosphokinase release from muscle cultures. Arch Neurol 1974; 31: 192–6.
  • 6
    Iannaccone ST, Bowen DE, Samaha FJ. Cell-mediated cytotoxicity and childhood dermatomyositis. Arch Neurol 1982; 39: 400–2.
  • 7
    Johnson RL, Fink CW, Ziff M. Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest 1972; 51: 2435–49.
  • 8
    Nagaraju K, Raben N, Yan B, Loeffler L, Danning C, Lee E, et al. Upregulation of transgenic MHC class I (H-2Kb) in the skeletal muscle leads to autoimmune myositis in transgenic mice. Arthritis Rheum 1999; 42 Suppl 9: S225.
  • 9
    Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996; 17: 466–70.
  • 10
    Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705.
  • 11
    Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94: 2125–9.
  • 12
    La Cava A, Nelson JL, Ollier WER, MacGregor A, Keystone EC, Thorne JC, et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest 1997; 100: 658–63.
  • 13
    Albert LJ, Inman RD. Molecular mimicry and auto immunity. N Engl J Med 1999; 341: 2068–74.
  • 14
    Martini A, Ravelli A, Albani S, Viola S, Scotta MS, Magrini U, et al. Recurrent juvenile dermatomyositis and cutaneous necrotizing arthritis with molecular mimicry between streptococcal type 5M protein and human skeletal myosin. J Pediatr 1992; 121: 739–42.
  • 15
    Rider LG, Okada S, Sherry DD, Wallace CA, Zemel LS, Jacobs JC, et al. Epidemiologic features and environmental exposures associated with illness onset in juvenile idiopathic inflammatory myopathy (JIIM). Arthritis Rheum 1995; 38 Suppl g: S362.
  • 16
    Koch MJ, Brody JA, Gillespie MM. Childhood polymyositis: a case-control study. Am J Epidemiol 1976; 104: 627–31.
  • 17
    Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162: 583–91.
  • 18
    Dale JB, Beachey EH. Human cytotoxic T lymphocytes evoked by group A streptococcal M proteins. J Exp Med 1987; 166: 1825–35.
  • 19
    Cunningham MW, Swerlick RA. Poly specificity of anti streptococcal murine monoclonal antibodies and their implications in auto immunity. J Exp Med 1986; 164: 998–1012.
  • 20
    Bisno AL, Berrios X, Quesney F, Monroe DM Jr, Dale JB, Beachey EH. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. Infect Immun 1982; 38: 573–9.
  • 21
    Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511.
  • 22
    Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S. Molecular analysis of human cardiac myosin cross-reactive B- and T cell epitopes of the group A streptococcal M5 protein. Infect Immun 1997; 65: 3913–23.
  • 23
    Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PMA, Assis RV, et al. Human heart-filtrating T cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995; 92: 415–20.
  • 24
    Bohan A, Peter JB, Bowman RL, Pearson CM. A computer assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255–86.
  • 25
    De Benedetti F, De Amici M, Aramini L, Ruperto N, Martini A. Correlation of serum neopterin levels with disease activity in juvenile dermatomyositis. Arch Dis Child 1993; 69: 232–5.
  • 26
    Rammensee HG, Friede T, Stefanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41: 178–228.
  • 27
    Quinn A, Ward K, Fischetti VA, Hemric M, Cunningham MW. Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun 1998; 66: 4418–24.
  • 28
    Albani S, Keystone EC, Nelson JL, Ollier WER, La Cava A, Montemayor AC, et al. Positive selection in auto immunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995; 1: 448–52.
  • 29
    Brander C, Wyss-Coray T, Mauri D, Bettens F, Pichler WJ. Carrier mediated uptake and presentation of a major histocompatibility complex class IB restricted peptide. Eur J Immunol 1993; 23: 3217–23.
    Direct Link:
  • 30
    Prakken B, Wauben W, Genini D, Samodal R, Barnett J, Mendivil A, et al. Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’. Nat Med 2000; 6: 1406–10.
  • 31
    Sugiura T, Murakawa Y, Nagai A, Kondo M, Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. Arthritis Rheum 1999; 42: 291–8.
    Direct Link:
  • 32
    Cherin P, Herson S, Crevon MC, Hauw JJ, Cervera P, Galanaud P, et al. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 1996; 23: 1135–42.
  • 33
    Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97: 2905–10.
  • 34
    Topaloglu H, Muntoni F, Dubowitz V, Sewry C. Expression of HLA class I antigens in skeletal muscle is a diagnostic marker of juvenile dermatomyositis. J Child Neurol 1997; 12: 60–3.
  • 35
    Thompson SD, Murray KJ, Grom AA, Passo MH, Choi E, Glass DN. Comparative sequence analysis of the human T cell receptor β chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Arthritis Rheum 1998; 41: 482–97.
    Direct Link:
  • 36
    Nepom BS, Nepom GT, Coleman M, Kwok WW. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc Natl Acad Sci U S A 1996; 93: 7202–6.
  • 37
    Pachman LM, Johasson O, Cannon RA, Friedman JM. HLA-B8 in juvenile dermatomyositis. Lancet 1977; 2: 567–8.
  • 38
    Friedman JM, Pachman LM, Maryjowski ML, Jonasson O, Battles ND, Crowe WE, et al. Immunogenic studies of juvenile dermatomyositis: HLA antigens in patients and their families. Tissue Antigens 1983; 21: 45–9.
    Direct Link:
  • 39
    Friedman JM, Pachman LM, Maryjowski ML, Radvany RM, Crowe WE, Hanson V, et al. Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies. Arthritis Rheum 1983; 26: 214–6.
    Direct Link:
  • 40
    Reed AM, Pachman LM, Hayford J, Ober C. Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 1998; 25: 1000–2.
  • 41
    Reed AM, Pachman LM, Ober C. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1*0501. Hum Immunol 1991; 32: 235–40.
  • 42
    Reed AM, Collins EJ, Shock LP, Klapper DG, Frelinger JA. Diminished class II associated Ii peptide binding to the JDM HLA DQA1*0501/DQB1*0301 molecule. J Immunol 1997; 159: 6260–5.
  • 43
    Rullan E, Sigal LH. Rheumatic fever. Curr Rheumatol Rep 2001; 3: 445–52.
  • 44
    Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, et al. New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 1997; 40: 1526–33.
    Direct Link:
  • 45
    Bonnin D, Albani S. Induction of oral tolerance to heat shock proteins in autoimmune diseases. Biotherapy 1998; 10: 213–21.
  • 46
    Prakken BJ, van der Zee R, Anderton SM, van Kooten PJ, Kuis W, van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A 1997; 94: 3284–9.
View Full Article (HTML) Get PDF (142K)